U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07124013) titled 'A Study of Olomorasib (LY3537982) in Healthy Japanese Participants' on Aug. 13.
Brief Summary: The purpose of this study is to compare and see how food affects the amount of olomorasib in the blood when olomorasib is taken in two different capsule forms. Participation in the study will last approximately 6 weeks.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Olomorasib
Administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Eli Lilly and Company
Disclaimer: Curated by HT Syndication....